Craneware (CRW) Stock Overview
Develops, licenses, and supports computer software for the healthcare industry in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
CRW Community Fair Values
See what 16 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Craneware plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£11.26 |
| 52 Week High | UK£26.44 |
| 52 Week Low | UK£9.88 |
| Beta | -0.15 |
| 1 Month Change | -25.33% |
| 3 Month Change | -20.82% |
| 1 Year Change | -49.28% |
| 3 Year Change | -23.66% |
| 5 Year Change | -48.82% |
| Change since IPO | 695.76% |
Recent News & Updates
CRW: 340B Timing Will Drive Future Earnings Upside Potential
Analysts have reduced their fair value estimate for Craneware from £30.08 to £25.51, reflecting updated assumptions for revenue growth, profit margins and future P/E expectations. What’s in the News for Craneware Craneware issued earnings guidance for the year ended 30 June 2026, with the Board expecting FY26 financial performance to be below market expectations.AI Driven Hospital Software And 340B Tailwinds Will Support Strong Long Term Upside
Catalysts About Craneware Craneware provides software to U.S. hospitals to improve operational efficiency and financial performance. What are the underlying business or industry changes driving this perspective?Recent updates
Shareholder Returns
| CRW | GB Healthcare Services | GB Market | |
|---|---|---|---|
| 7D | -16.5% | -17.3% | 1.7% |
| 1Y | -49.3% | -49.3% | 19.6% |
Return vs Industry: CRW matched the UK Healthcare Services industry which returned -49.3% over the past year.
Return vs Market: CRW underperformed the UK Market which returned 19.6% over the past year.
Price Volatility
| CRW volatility | |
|---|---|
| CRW Average Weekly Movement | 9.2% |
| Healthcare Services Industry Average Movement | 5.5% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in GB Market | 10.7% |
| 10% least volatile stocks in GB Market | 2.9% |
Stable Share Price: CRW's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: CRW's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 765 | Keith Neilson | www.thecranewaregroup.com |
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. It provides solutions, such as Trisus Pricing Analyzer and Transparency, a solution that optimizes and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity requirements; Trisus Claims Informatics, a retrospective charge capture analytical application; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit solution for government and commercial payors. The company also offers Trisus Decision Support; Trisus Labor Productivity, which enables healthcare providers to manage, analyze, and plan the deployment of workforce; Trisus Medication Analytic solutions that prioritize, diagnose, and resolve issues in medication systems; and Trisus Supplies Assistant solutions which supplies charged data.
Craneware plc Fundamentals Summary
| CRW fundamental statistics | |
|---|---|
| Market cap | UK£377.39m |
| Earnings (TTM) | UK£16.79m |
| Revenue (TTM) | UK£157.89m |
Is CRW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRW income statement (TTM) | |
|---|---|
| Revenue | US$211.33m |
| Cost of Revenue | US$29.28m |
| Gross Profit | US$182.06m |
| Other Expenses | US$159.58m |
| Earnings | US$22.48m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.66 |
| Gross Margin | 86.15% |
| Net Profit Margin | 10.64% |
| Debt/Equity Ratio | 6.9% |
How did CRW perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/07 18:13 |
| End of Day Share Price | 2026/07/07 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Craneware plc is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Chantry | Berenberg |
| Alexander James Short | Berenberg |
| Ciaran Donnelly | Berenberg |